Great Western Mining (GWMO ) has submitted an application to the OTC Markets Group for its ordinary shares to be cross-traded on the OTCID market in the United States. 

The idea is to enhance visibility in the North American capital markets and thereby broaden the company’s investor base.  

By trading on the OTCID, Great Western will engage directly with US investors, providing them with the same level of information and disclosure available to shareholders in the United Kingdom, but through US-facing platforms and portals. 

Additionally, the OTCID cross-trading facility will enable US investors to access Great Western's ordinary shares in US dollars, during US market hours.

The OTCID Market is recognised as an established public market for developing companies and does not require issuers to meet additional financial reporting and compliance standards. 

It is expected that approval and admission to trading will take up to six weeks and a further announcement will be made in due course.  

"Subject to the necessary approval and admission process, trading on OTCID will open Great Western to a new and diverse pool of potential investors in the US who are seeking exposure to metal development, including strategic metals such as tungsten,” said Great Western’s chairman Brian Hall. 

“Our assets are located in a Tier 1 jurisdiction in the US, and I believe it to be a natural next step for us to enable North American investors to trade, and benefit from, assets within their own country. Trading on the OTCID is an important component of this vision, offering investors a significant and domestically sourced pathway to gain exposure to this high-growth and strategically important commodities."

 

 

View from Vox

 

Great Western has US assets, specifically in gold tungsten and copper – all very desirable commodities in the current moment. Location inside the US commands a premium these days, but that’s easier to unlock if US investors have local access to the story and the investment opportunity. Great Western’s move makes sense in that context, especially since an OTC listing comes at relatively low cost. The shares have risen by more than 50% over the past three months.